An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
intestinal in Camelus dromedarius (2)All 2 Gene records
StatPearls [Internet].
Treasure Island (FL): StatPearls Publishing; 2025 Jan-.
Top results in this bookTable of Contents
Surgical Treatment: Evidence-Based and Problem-Oriented.
Holzheimer RG, Mannick JA, editors.
Munich: Zuckschwerdt; 2001.
Biologics versus Immunomodulators or Antibiotics for the Management of Fistulizing Crohn’s Disease: A Review of Comparative Clinical Effectiveness and Cost-Effectiveness [Internet].
Young C, Campbell K.
Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2019 Mar 29.
GeneReviews® [Internet].
Adam MP, Bick S, Mirzaa GM, et al., editors.
Seattle (WA): University of Washington, Seattle; 1993-2026.
Database of Abstracts of Reviews of Effects (DARE): Quality-assessed Reviews [Internet].
York (UK): Centre for Reviews and Dissemination (UK); 1995-.
Upadacitinib (Rinvoq): CADTH Reimbursement Review: Therapeutic area: Crohn disease [Internet].
Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2024 Mar.
Safety of Vaccines Used for Routine Immunization in the United States: An Update [Internet].
Gidengil C, Goetz MB, Maglione M, et al.
Rockville (MD): Agency for Healthcare Research and Quality (US); 2021 May. (Comparative Effectiveness Review, No. 244.)
Clinical and Economic Review Report: Vedolizumab (ENTYVIO SC): Takeda Canada Inc. Indication: Crohn disease [Internet].
Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2021 Apr.
Ustekinumab (Stelara) [Internet].
Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2017 Apr.
Endotext [Internet].
Feingold KR, Adler RA, Ahmed SF, et al., editors.
South Dartmouth (MA): MDText.com, Inc.; 2000-.
The clinical effectiveness and cost-effectiveness of ablative therapies in the management of liver metastases: systematic review and economic evaluation.
Loveman E, Jones J, Clegg AJ, et al.
Southampton (UK): NIHR Journals Library; 2014 Jan. (Health Technology Assessment, No. 18.7.)
Dialysis Modalities for the Treatment of End-Stage Kidney Disease: A Health Technology Assessment [Internet].
Sinclair A, Cimon K, Loncar M, et al.
Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2017 Mar. (CADTH Optimal Use Report, No. 6.2b.)
Early Biologic Treatment versus Conventional Treatment for the Management of Crohn’s Disease: A Review of Comparative Clinical Effectiveness and Cost-Effectiveness [Internet].
Thompson W, Argáez C.
Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2019 Feb 13.
Short- and Long-Term Outcomes after Bariatric Surgery in the Medicare Population [Internet].
Panagiotou OA, Markozannes G, Kowalski R, et al.
Rockville (MD): Agency for Healthcare Research and Quality (US); 2018 Jan 7.
Prognostic tools for identification of high risk in people with Crohn’s disease: systematic review and cost-effectiveness study.
Edwards SJ, Barton S, Bacelar M, et al.
Southampton (UK): NIHR Journals Library; 2021 Mar. (Health Technology Assessment, No. 25.23.)
Entyvio (Vedolizumab) [Internet].
Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2016 Dec.
The use of fibrin sealant during non-emergency surgery: a systematic review of evidence of benefits and harms.
Edwards SJ, Crawford F, van Velthoven MH, et al.
Southampton (UK): NIHR Journals Library; 2016 Dec. (Health Technology Assessment, No. 20.94.)
A Systematic Review and Economic Evaluation of the Use of Tumour Necrosis Factor-Alpha (TNF-α) Inhibitors, Adalimumab and Infliximab, for Crohn's Disease.
Dretzke J, Edlin R, Round J, et al.
Southampton (UK): NIHR Journals Library; 2011 Feb. (Health Technology Assessment, No. 15.6.)
Clinical Methods: The History, Physical, and Laboratory Examinations. 3rd edition.
Walker HK, Hall WD, Hurst JW, editors.
Boston: Butterworths; 1990.
Multiple Dose Pharmacokinetic Study of Meropenem in Young Infants (<91 days) with Suspected or Complicated Intra-abdominal Infections [Internet].
Benjamin D, Smith PB, Capparelli EV, et al.
Bethesda (MD): National Institute of Child Health and Human Development (US); 2011 Jul 15.
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on